Doximity (NYSE:DOCS) Shares Climb 6.9% – What’s Next?

Doximity, Inc. (NYSE:DOCS)’s stock price traded up 6.9% on Wednesday. The stock traded as high as $28.25 and last traded at $28.34. Approximately 1,223,550 shares traded hands during trading, a decline of 70% from the average session volume of 4,011,666 shares. The stock had previously closed at $26.52.

Key Doximity News

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity recently gained while the broader market declined, suggesting relative strength and possible buying interest after prior weakness. The available market commentary did not identify a new fundamental catalyst. Doximity Gains As Market Dips
• Neutral Sentiment: Multiple law firms—including Kaplan Fox, Robbins Geller, Rosen, Pomerantz, Wolf Haldenstein and others—are soliciting investors to participate in or seek lead-plaintiff status in a securities class action. The notices largely repeat the same allegations and November 16, 2026 deadline rather than announcing a new court ruling. Kaplan Fox Doximity Investor Alert
• Negative Sentiment: The lawsuit alleges that Doximity and certain executives made false or misleading statements between August 8, 2024, and May 13, 2026, including claims that the company could gain market share while competitors offered more favorable pricing and engagement models. Other allegations involve traditional advertising formats losing ground to programmatic and social-media competitors. These claims remain allegations and could expose Doximity to legal costs, reputational damage and potential financial liability. Robbins LLP Doximity Investigation

Wall Street Analyst Weigh In

A number of analysts recently issued reports on DOCS shares. Wolfe Research raised Doximity to an “outperform” rating in a research note on Thursday, August 13th. Barclays upped their price target on shares of Doximity from $20.00 to $27.00 and gave the company an “equal weight” rating in a report on Friday, August 21st. Needham & Company LLC reissued a “buy” rating and set a $41.00 price objective on shares of Doximity in a research report on Friday, August 7th. Truist Financial raised their price objective on shares of Doximity from $19.00 to $24.00 and gave the stock a “hold” rating in a report on Thursday, August 13th. Finally, Wells Fargo & Company cut shares of Doximity from an “equal weight” rating to an “underweight” rating and set a $18.00 price objective on the stock. in a research report on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, fourteen have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, Doximity presently has an average rating of “Hold” and an average target price of $31.95.

Doximity Price Performance

The business has a 50-day moving average of $24.72 and a 200-day moving average of $23.17. The firm has a market cap of $5.03 billion, a price-to-earnings ratio of 33.23, a P/E/G ratio of 20.49 and a beta of 1.25.

Doximity (NYSE:DOCS) last released its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.13. Doximity had a return on equity of 18.06% and a net margin of 25.48%.The business had revenue of $156.62 million for the quarter. During the same quarter in the previous year, the company posted $0.36 EPS. The business’s revenue was up 7.3% on a year-over-year basis. As a group, equities analysts anticipate that Doximity, Inc. will post 0.74 EPS for the current fiscal year.

Insider Transactions at Doximity

In related news, Director Kira Wampler sold 2,000 shares of the firm’s stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $24.95, for a total value of $49,900.00. Following the completion of the transaction, the director directly owned 19,839 shares of the company’s stock, valued at approximately $494,983.05. This trade represents a 9.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Siddharth Sitaram sold 2,077 shares of the business’s stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $26.02, for a total transaction of $54,043.54. Following the transaction, the chief accounting officer owned 96,045 shares in the company, valued at approximately $2,499,090.90. The trade was a 2.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 13,347 shares of company stock worth $441,412 in the last 90 days. Corporate insiders own 31.80% of the company’s stock.

Institutional Trading of Doximity

Large investors have recently added to or reduced their stakes in the company. Tidal Investments LLC grew its position in shares of Doximity by 207.9% in the 2nd quarter. Tidal Investments LLC now owns 43,761 shares of the company’s stock valued at $908,000 after acquiring an additional 29,546 shares during the period. Engineers Gate Manager LP raised its holdings in shares of Doximity by 15.9% in the 2nd quarter. Engineers Gate Manager LP now owns 285,198 shares of the company’s stock valued at $5,915,000 after purchasing an additional 39,223 shares during the period. RFG Advisory LLC bought a new stake in shares of Doximity in the 2nd quarter valued at about $1,161,000. Nykredit A S acquired a new stake in Doximity in the 2nd quarter valued at about $96,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Doximity in the 2nd quarter valued at about $1,515,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

About Doximity

Doximity, Inc operates a digital platform for U.S. medical professionals. Its network enables physicians and other healthcare providers to communicate, collaborate, access medical news and research, maintain professional profiles, and connect with colleagues and patients.

The company offers a range of tools for healthcare organizations and professionals, including telehealth services, digital faxing, scheduling and communication products, and solutions for recruiting and marketing. Doximity also provides pharmaceutical and healthcare companies with digital engagement services designed to reach medical professionals through its platform.

Founded in 2010, Doximity is headquartered in San Francisco and primarily serves the United States healthcare market.